My work in the clinical translation of tumor and T-cell immunology began at the NCI’s Biological Response Modifiers Program (BRMP) in 1990 and continued as Associate Professor at the Penn State University College of Medicine before joining the Earle A. Chiles Research Institute (EACRI) at Providence Cancer Center in 2002. I work daily with EACRI researchers translating basic science to clinical trials in my roles as Director of Genitourinary Oncology Research, Director of the Cytokine and Adoptive Immunotherapy, and the Melanoma Programs. This work has been recognized with the Robert W. Franz Chair for Clinical Research at our Institute.